Hemostatic agent, gastrointestinal, topical

Intravertebral body fracture augmentation with implant (e.g., metal, polymer)

Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval

Terminated December 31, 2014.

Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)

Catheter, transluminal atherectomy, directional

Brachytherapy needle

Brachytherapy source, non-stranded, gold-198, per source

Brachytherapy source, non-stranded, high dose rate iridium-192, per source

Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source

Cardioverter-defibrillator, dual chamber (implantable)

Cardioverter-defibrillator, single chamber (implantable)

Catheter, transluminal atherectomy, rotational

Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)

Catheter, balloon dilatation, non-vascular

Catheter, balloon tissue dissector, non-vascular (insertable)

Catheter, brachytherapy seed administration

Catheter, drainage

Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)

Catheter, electrophysiology, diagnostic, other than 3d mapping (20 or more electrodes)

Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping

Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, other than cool-tip

Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable)

Endoscope, single-use (i.e. disposable), urinary tract, imaging/illumination device (insertable)

Endoscope, single-use (i.e. disposable), upper gi, imaging/illumination device (insertable)

Endoscope, retrograde imaging/illumination colonoscope device (implantable)

Catheter, hemodialysis/peritoneal, long-term

Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)

Catheter, hemodialysis/peritoneal, short-term

Catheter, intravascular ultrasound

Catheter, intradiscal

Catheter, intraspinal

Catheter, pacing, transesophageal

Catheter, thrombectomy/embolectomy

Catheter, ureteral

Catheter, intracardiac echocardiography

Closure device, vascular (implantable/insertable)

Catheter, transluminal intravascular lithotripsy, coronary

Connective tissue, human (includes fascia lata)

Connective tissue, non-human (includes synthetic)

Event recorder, cardiac (implantable)

Adhesion barrier

Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away

Generator, neurostimulator (implantable), non-rechargeable

Graft, vascular

Guide wire

Imaging coil, magnetic resonance (insertable)

Repair device, urinary, incontinence, with sling graft

Infusion pump, programmable (implantable)

Retrieval device, insertable (used to retrieve fractured medical devices)

Joint device (implantable)

Lead, cardioverter-defibrillator, endocardial single coil (implantable)

Lead, neurostimulator (implantable)

Lead, pacemaker, transvenous vdd single pass

Lens, intraocular (new technology)

Mesh (implantable)

Morcellator

Ocular implant, aqueous drainage assist device

Ocular device, intraoperative, detached retina

Pacemaker, dual chamber, rate-responsive (implantable)

Pacemaker, single chamber, rate-responsive (implantable)

Patient programmer, neurostimulator

Port, indwelling (implantable)

Prosthesis, breast (implantable)

Prosthesis, penile, inflatable

Retinal tamponade device, silicone oil

Prosthesis, urinary sphincter (implantable)

Receiver and/or transmitter, neurostimulator (implantable)

Septal defect implant system, intracardiac

Integrated keratoprosthesis

Surgical tissue localization and excision device (implantable)

Generator, neurostimulator (implantable), with rechargeable battery and charging system

Interspinous process distraction device (implantable)

Generator, neurostimulator (implantable), high frequency, with rechargeable battery and charging system

Generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leads

Generator, cardiac contractility modulation (implantable)

Generator, neurostimulator (implantable), non-rechargeable with carotid sinus baroreceptor stimulation lead(s)

Generator, neurostimulator (implantable), includes closed feedback loop leads and all implantable components, with rechargeable battery and charging system

Generator, neurostimulator (implantable), non-rechargeable, with implantable stimulation lead and external paired stimulation controller

Powered bone marrow biopsy needle

Interbody cage, anterior, lateral or posterior, personalized (implantable)

Autograft suspension, including cell processing and application, and all system components

Monitor, cardiac, including intracardiac lead and all system components (implantable)

Pressure sensor system, includes all components (e.g., introducer, sensor), intramuscular (implantable), excludes mobile (wireless) software application

Terminated March 31, 2023.

Iris prosthesis

Lens, intraocular (telescopic)

Retinal prosthesis, includes all internal and external components

Terminated December 31, 2022.

Retinal prosthesis, includes all internal and external components; add-on to c1841

Terminated December 31, 2022.

Skin substitute, synthetic, resorbable, per square centimeter

Terminated December 31, 2022.

Stent, coated/covered, with delivery system

Stent, coated/covered, without delivery system

Stent, non-coated/non-covered, with delivery system

Stent, non-coated/non-covered, without delivery system

Material for vocal cord medialization, synthetic (implantable)

Vena cava filter

Dialysis access system (implantable)

Cardioverter-defibrillator, other than single or dual chamber (implantable)

Adapter/extension, pacing lead or neurostimulator lead (implantable)

Embolization protective system

Catheter, transluminal angioplasty, laser

Catheter, extravascular tissue ablation, any modality (insertable)

Catheter, guiding (may include infusion/perfusion capability)

Catheter, ablation, non-cardiac, endovascular (implantable)

Implantable/insertable device, not otherwise classified

No implantable/insertable device used with device-intensive procedures

Infusion pump, non-programmable, permanent (implantable)

Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away

Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away

Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser

Lead, cardioverter-defibrillator, endocardial dual coil (implantable)

Lead, cardioverter-defibrillator, other than endocardial single or dual coil (implantable)

Lead, neurostimulator test kit (implantable)

Lead, pacemaker, other than transvenous vdd single pass

Lead, pacemaker/cardioverter-defibrillator combination (implantable)

Lead, left ventricular coronary venous system

Catheter, pressure-generating, one-way valve, intermittently occlusive

Probe, image-guided, robotic, waterjet ablation

Lung biopsy plug with delivery system

Probe, percutaneous lumbar discectomy

Sealant, pulmonary, liquid

Brachytherapy source, non-stranded, yttrium-90, per source

Stent, non-coronary, temporary, without delivery system

Probe/needle, cryoablation

Pacemaker, dual chamber, non rate-responsive (implantable)

Pacemaker, single chamber, non rate-responsive (implantable)

Pacemaker, other than single or dual chamber (implantable)

Prosthesis, penile, non-inflatable

Catheter, transluminal angioplasty, drug-coated, non-laser

Implantable wireless pulmonary artery pressure sensor with delivery catheter, including all system components

Stent, non-coronary, temporary, with delivery system

Infusion pump, non-programmable, temporary (implantable)

Catheter, suprapubic/cystoscopic

Catheter, occlusion

Introducer/sheath, other than guiding, other than intracardiac electrophysiological, laser

Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, cool-tip

Repair device, urinary, incontinence, without sling graft

Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source

Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source

Brachytherapy linear source, non-stranded, palladium-103, per 1 mm

Brachytherapy source, non-stranded, ytterbium-169, per source

Brachytherapy source, stranded, iodine-125, per source

Brachytherapy source, non-stranded, iodine-125, per source

Brachytherapy source, stranded, palladium-103, per source

Brachytherapy source, non-stranded, palladium-103, per source

Brachytherapy source, stranded, cesium-131, per source

Brachytherapy source, non-stranded, cesium-131, per source

Brachytherapy source, cesium-131 chloride solution, per millicurie

Brachytherapy planar source, palladium-103, per square millimeter

Brachytherapy source, stranded, not otherwise specified, per source

Brachytherapy source, non-stranded, not otherwise specified, per source

Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area

Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)

Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children

Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)

Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area

Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)

Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children

Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)

Debridement, bone including epidermis, dermis, subcutaneous tissue, muscle and/or fascia, if performed, first 20 sq cm or less with manual preparation and insertion of deep (eg, subfacial) drug-delivery device(s)

Percutaneous breast biopsies using stereotactic guidance, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral and bilateral (for single lesion biopsy, use appropriate code)

Percutaneous breast biopsies using magnetic resonance guidance, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral or bilateral (for single lesion biopsy, use appropriate code)

Open biopsy or excision of deep cervical node(s) with intraoperative identification (eg, mapping) of sentinel lymph node(s) including injection of non-radioactive dye when performed

Percutaneous vertebroplasties (bone biopsies included when performed), first cervicothoracic and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance

Percutaneous vertebroplasties (bone biopsies included when performed), first lumbosacral and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance

Arthrodesis, interphalangeal joints, with or without internal fixation

Percutaneous vertebral augmentations, first thoracic and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (eg, kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance

Percutaneous vertebral augmentations, first lumbar and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (eg, kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance

Bronchoscopy, rigid or flexible, diagnostic with cell washing(s) when performed, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed

Bronchoscopy, rigid or flexible, with bronchial alveolar lavage(s), with computer-assisted image-guided navigation, including fluoroscopic guidance when performed

Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed

Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic intervention(s) for peripheral lesion(s), including fluoroscopic guidance when performed

Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty of central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report

Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with all angioplasty in the central dialysis segment, and transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report

Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with dialysis circuit permanent endovascular embolization or occlusion of main circuit or any accessory veins, including all required imaging, radiological supervision and interpretation, image documentation and report

Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report

Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation

Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging, supervision, interpretation and report

Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress

Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) includes intraprocedural injection(s) for bypass graft angiography with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation

Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography with right heart catheterization with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report

Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right heart catheterization, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress

Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report

Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress

Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report

Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress

Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report

Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress

Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress

Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty, peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty and all angioplasty in the central dialysis segment, with transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all imaging, radiological supervision and interpretation, documentation and report

Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal angioplasty with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation

Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), initial artery, open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation

Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with transcatheter placement of radiation delivery device for subsequent coronary intravascular brachytherapy

Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with atherectomy, includes angioplasty within the same vessel, when performed with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation

Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal stent placement(s), includes angioplasty within the same vessel, when performed, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation

Insertion of new or replacement of permanent pacemaker with atrial transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable debribrillator or pacemake pulse generator (eg, for upgrade to dual chamber system)

Insertion of new or replacement of permanent pacemaker with ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defribrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)

Insertion of new or replacement of permanent pacemaker with atrial and ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)

Removal of permanent pacemaker pulse generator with replacement of pacemaker pulse generator, dual lead system, with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)

Diagnostic endoscopic retrograde cholangiopancreatography (ercp), including collection of specimen(s) by brushing or washing, when performed, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)

Endoscopic retrograde cholangiopancreatography (ercp) with biopsy, single or multiple, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)

Endoscopic retrograde cholangiopancreatography (ercp) with sphincterotomy/papillotomy, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)

Endoscopic retrograde cholangiopancreatography (ercp) with removal of calculi/debris from biliary/pancreatic duct(s), with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)

Percutaneous exchange of biliary drainage catheter (eg, external, internal-external, or conversion of internal-external to external only), with removal of calculi/debris from biliary duct(s) and/or gallbladder, including destruction of calculi by any method (eg, mechanical, electrohydraulic, lithotripsy) when performed, including diagnostic cholangiography(ies) when performed, imaging guidance (eg, fluoroscopy), and all associated radiological supervision and interpretation

Removal and replacement of externally accessible nephroureteral catheter (eg, external/internal stent) requiring fluoroscopic guidance, with ureteral stricture balloon dilation, including imaging guidance and all associated radiological supervision and interpretation

Convert nephrostomy catheter to nephroureteral catheter, percutaneous via pre-existing nephrostomy tract, with ureteral stricture balloon dialation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation

Exchange nephrostomy catheter, percutaneous, with ureteral stricture balloon dilation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation

Change of ureterostomy tube or externally accessible ureteral stent via ileal conduit with ureteral stricture balloon dilation, including imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation

Cystourethroscopy, with biopsy(ies) with adjuctive blue light cystoscopy with fluorescent imaging agent

Excision of major peripheral nerve neuroma, except sciatic, with implantation of nerve end into bone or muscle

Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography and right heart catheterization with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress, initial vessel

Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed

Cystourethroscopy with adjunctive blue light cystoscopy with fluorescent imaging agent

Thyroidectomy, total or complete with parathyroid autotransplantation

Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, initial 15-29 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service

Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, initial 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service

Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, each additional 15 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service (list separately in addition to code for primary service)

Magnetic resonance angiography with contrast, abdomen

Magnetic resonance angiography without contrast, abdomen

Magnetic resonance angiography without contrast followed by with contrast, abdomen

Magnetic resonance imaging with contrast, breast; unilateral

Magnetic resonance imaging without contrast, breast; unilateral

Terminated December 31, 2018.

Magnetic resonance imaging without contrast followed by with contrast, breast; unilateral

Magnetic resonance imaging with contrast, breast; bilateral

Magnetic resonance imaging without contrast, breast; bilateral

Terminated December 31, 2018.

Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral

Magnetic resonance angiography with contrast, chest (excluding myocardium)

Magnetic resonance angiography without contrast, chest (excluding myocardium)

Magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardium)

Magnetic resonance angiography with contrast, lower extremity

Magnetic resonance angiography without contrast, lower extremity

Magnetic resonance angiography without contrast followed by with contrast, lower extremity

Magnetic resonance angiography with contrast, pelvis

Magnetic resonance angiography without contrast, pelvis

Magnetic resonance angiography without contrast followed by with contrast, pelvis

Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete

Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; follow-up or limited study

Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography

Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study

Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, real time with image documentation (2d) (with or without m-mode recording); including probe placement, image acquisition, interpretation and report

Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report

Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for monitoring purposes, including probe placement, real time 2-dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis

Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report

Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography

Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision

Magnetic resonance angiography with contrast, spinal canal and contents

Magnetic resonance angiography without contrast, spinal canal and contents

Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents

Magnetic resonance angiography with contrast, upper extremity

Magnetic resonance angiography without contrast, upper extremity

Magnetic resonance angiography without contrast followed by with contrast, upper extremity

Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)

Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump

Injection, cerliponase alfa, 1 mg

Terminated December 31, 2018.

Injection, c-1 esterase inhibitor (human), haegarda, 10 units

Terminated December 31, 2018.

Injection, triptorelin extended release, 3.75 mg

Terminated December 31, 2018.

Injection, obinutuzumab, 10 mg

Terminated December 31, 2014.

Injection, elosulfase alfa, 1mg

Terminated December 31, 2014.

Injection, testosterone undecanoate, 1 mg

Terminated December 31, 2014.

Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine

Terminated December 31, 2018.

Injection, ramucirumab, 5 mg

Terminated December 31, 2015.

Injection, vedolizumab, 1 mg

Terminated December 31, 2015.

Injection, pembrolizumab, 1 mg

Terminated December 31, 2015.

Injection, inotuzumab ozogamicin, 0.1 mg

Terminated December 31, 2018.

Injection, guselkumab, 1 mg

Terminated December 31, 2018.

Injection, copanlisib, 1 mg

Terminated December 31, 2018.

Lutetium lu 177, dotatate, therapeutic, 1 mci

Terminated December 31, 2018.

Injection, voretigene neparvovec-rzyl, 1 billion vector genome

Terminated December 31, 2018.

Injection, fosnetupitant 235 mg and palonosetron 0.25 mg

Terminated December 31, 2018.

Injection, dexamethasone 9%, intraocular, 1 mcg

Terminated December 31, 2018.

Injection, aripiprazole lauroxil (aristada initio), 1 mg

Terminated September 30, 2019.

Injection, patisiran, 0.1 mg

Terminated September 30, 2019.

Injection, risperidone (perseris), 0.5 mg

Terminated September 30, 2019.

Injection, mogamulizumab-kpkc, 1 mg

Terminated September 30, 2019.

Injection, plazomicin, 5 mg

Terminated September 30, 2019.

Injection, fremanezumab-vfrm, 1mg

Terminated September 30, 2019.

Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg

Terminated June 30, 2020.

Injection, bendamustine hcl (belrapzo), 1 mg

Terminated June 30, 2019.

Injection, levoleucovorin, 1 mg

Terminated December 31, 2019.

Injection, cemiplimab-rwlc, 1 mg

Terminated September 30, 2019.

Injection, moxetumomab pasudotox-tdfk, 0.01 mg

Terminated September 30, 2019.

Cocaine hydrochloride nasal solution (goprelto), 1 mg

Injection, caplacizumab-yhdp, 1 mg

Dexamethasone, lacrimal ophthalmic insert, 0.1 mg

Terminated September 30, 2019.

Injection, tagraxofusp-erzs, 10 mcg

Terminated September 30, 2019.

Injection, emapalumab-lzsg, 1 mg

Terminated September 30, 2019.

Injection, omadacycline, 1 mg

Terminated September 30, 2019.

Injection, ravulizumab-cwvz, 10 mg

Terminated September 30, 2019.

Injection, crizanlizumab-tmca, 1 mg

Terminated June 30, 2020.

Injection, lefamulin (xenleta), 1 mg

Terminated June 30, 2020.

Injection, brexanolone, 1mg

Terminated September 30, 2020.

Injection, givosiran, 0.5 mg

Terminated June 30, 2020.

Injection, cetirizine hydrochloride, 1 mg

Terminated June 30, 2020.

Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo) 0.5 mg

Terminated June 30, 2020.

Injection, meloxicam, 1 mg

Terminated September 30, 2020.

Fluoroestradiol f18, diagnostic, 1 mci

Terminated December 31, 2020.

Injection, teprotumumab-trbw, 10 mg

Terminated September 30, 2020.

Injection, daratumumab 10 mg and hyaluronidase-fihj

Terminated December 31, 2020.

Injection, eptinezumab-jjmr, 1 mg

Terminated September 30, 2020.

Mitomycin pyelocalyceal instillation, 1 mg

Terminated December 31, 2020.

Injection, romidepsin, non-lyophilized (e.g. liquid), 1mg

Terminated September 30, 2021.

Injection, sacituzumab govitecan-hziy, 2.5 mg

Terminated December 31, 2020.

Gallium ga-68, dotatoc, diagnostic, 0.01 mci

Copper cu-64, dotatate, diagnostic, 1 millicurie

Terminated March 31, 2021.

Injection, belantamab mafodontin-blmf, 0.5 mg

Terminated March 31, 2021.

Injection, tafasitamab-cxix, 2 mg

Terminated March 31, 2021.

Injection, viltolarsen, 10 mg

Terminated March 31, 2021.

Injection, immune globulin (asceniv), 500 mg

Terminated March 31, 2021.

Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Terminated March 31, 2021.

Injection, lumasiran, 0.5 mg

Terminated June 30, 2021.

Injection, casimersen, 10 mg

Terminated September 30, 2021.

Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Terminated September 30, 2021.

Injection, cabotegravir and rilpivirine, 2mg/3mg

Terminated September 30, 2021.

Injection, trilaciclib, 1 mg

Terminated September 30, 2021.

Injection, evinacumab-dgnb, 5 mg

Terminated September 30, 2021.

Injection, melphalan flufenamide hydrochloride, 1 mg

Terminated September 30, 2021.

Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Terminated December 31, 2021.

Injection, dostarlimab-gxly, 100 mg

Terminated December 31, 2021.

Injection, amivantamab-vmjw, 10 mg

Terminated December 31, 2021.

Injection, loncastuximab tesirine-lpyl, 0.1 mg

Terminated March 31, 2022.

Injection, avalglucosidase alfa-ngpt, 4 mg

Terminated March 31, 2022.

Injection, anifrolumab-fnia, 1 mg

Terminated March 31, 2022.

Injection, cyclophosphamide, (auromedics), 10 mg

Terminated March 31, 2022.

Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg

Bupivacaine, collagen-matrix implant, 1 mg

Injection, plasminogen, human-tvmh, 1 mg

Terminated June 30, 2022.

Injection, sirolimus protein-bound particles, 1 mg

Terminated June 30, 2022.

Injection, triamcinolone acetonide, suprachoroidal (xipere), 1 mg

Terminated June 30, 2022.

Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg

Terminated June 30, 2022.

Inj, sutimlimab-jome, 10 mg

Terminated September 30, 2022.

Inj, tebentafusp-tebn, 1 mcg

Terminated September 30, 2022.

Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram

Terminated September 30, 2022.

Inj, faricimab-svoa, 0.1 mg

Terminated September 30, 2022.

Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Terminated September 30, 2022.

Injection, oliceridine, 0.1 mg

Injection, pantoprazole sodium, per vial

Injection, argatroban, per 5 mg

Terminated December 31, 2016.

Mometasone furoate sinus implant, 10 micrograms (sinuva)

Terminated March 31, 2021.

Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity

Terminated June 30, 2021.

Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.

Terminated December 31, 2014.

Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.

Terminated December 31, 2014.

Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.

Terminated December 31, 2014.

Injection, factor viii, fc fusion protein, (recombinant), per i.u.

Terminated March 31, 2015.

Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.

Terminated December 31, 2016.

Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.

Terminated December 31, 2016.

Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.

Terminated December 31, 2016.

Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.

Terminated December 31, 2017.

Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.

Terminated June 30, 2019.

Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg

Terminated December 31, 2022.

Cocaine hydrochloride nasal solution (numbrino), 1 mg

Injection, bupivacaine (posimir), 1 mg

Injection, aprepitant, (aponvie), 1 mg

Injection, mirvetuximab soravtansine-gynx, 1 mg

Terminated June 30, 2023.

Injection, tremelimumab-actl, 1 mg

Terminated June 30, 2023.

Injection, teclistamab-cqyv, 0.5 mg

Terminated June 30, 2023.

Injection, teplizumab-mzwv, 5 mcg

Terminated June 30, 2023.

Xenon xe-129 hyperpolarized gas, diagnostic, per study dose

Injection, pegcetacoplan, 1 mg

Injection, clevidipine butyrate, 1 mg

Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml

Injection, lacosamide, 1 mg

Injection, bevacizumab, 0.25 mg

Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose

Terminated December 31, 2018.

Lidocaine 70 mg/tetracaine 70 mg, per patch

Injection, bupivacaine liposome, 1 mg

Injection, glucarpidase, 10 units

Puraply, and puraply antimicrobial, any type, per square centimeter

Terminated December 31, 2016.

Microporous collagen implantable tube (neuragen nerve guide), per centimeter length

Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter length

Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter

Collagen nerve cuff (neuromatrix), per 0.5 centimeter length

Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter

Dermal substitute, native, non-denatured collagen, fetal bovine origin (surgimend collagen matrix), per 0.5 square centimeters

Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per 0.5 cc

Dermal substitute, native, non-denatured collagen, neonatal bovine origin (surgimend collagen matrix), per 0.5 square centimeters

Collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter length

Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold strip), per 0.5 cc

Skin substitute, integra meshed bilayer wound matrix, per square centimeter

Porcine implant, permacol, per square centimeter

Unclassified drugs or biologicals

Iodine i-131 iobenguane, diagnostic, 1 millicurie

Terminated December 31, 2019.

Iodine i-131 iobenguane, therapeutic, 1 millicurie

Terminated December 31, 2019.

Injection, ferric carboxymaltose, 1 mg

Terminated June 30, 2014.

Injection, belinostat, 10 mg

Terminated December 31, 2015.

Injection, dalbavancin, 10 mg

Terminated December 31, 2015.

Injection, oritavancin, 10 mg

Terminated December 31, 2015.

Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 units

Terminated December 31, 2015.

Injection, tedizolid phosphate, 1 mg

Terminated December 31, 2015.

Injection, phenylephrine and ketorolac, 4 ml vial

Terminated September 30, 2019.

Netupitant 300 mg and palonosetron 0.5 mg, oral

Terminated June 30, 2015.

Injection, blinatumomab, 1 mcg

Terminated December 31, 2015.

Injection, fluocinolone acetonide intravitreal implant, 0.01 mg

Terminated December 31, 2015.

Injection, peramivir, 1 mg

Terminated December 31, 2015.

Injection, ceftolozane 50 mg and tazobactam 25 mg

Terminated December 31, 2015.

Injection, nivolumab, 1 mg

Terminated December 31, 2015.

Injection, pasireotide long acting, 1 mg

Terminated December 31, 2015.

Injection, siltuximab, 10 mg

Terminated December 31, 2015.

Injection, isavuconazonium sulfate, 1 mg

Terminated December 31, 2015.

Injection, sulfur hexafluoride lipid microsphere, per ml

Terminated December 31, 2015.

Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries

Terminated June 30, 2016.

Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries

Terminated June 30, 2016.

Injection, cangrelor, 1 mg

Choline c 11, diagnostic, per study dose

Terminated December 31, 2016.

Injection, delafloxacin, 1 mg

Injection, aprepitant, 1 mg

Terminated December 31, 2018.

Injection, rolapitant, 0.5 mg

Terminated December 31, 2018.

Hyaluronan or derivative, durolane, for intra-articular injection, per dose

Terminated December 31, 2018.

Injection, benralizumab, 1 mg

Terminated December 31, 2018.

Injection, rituximab and hyaluronidase, 10 mg

Terminated December 31, 2018.

Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u.

Terminated December 31, 2018.

Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg

Terminated June 30, 2018.

Injection, aripiprazole lauroxil, 1 mg

Terminated December 31, 2016.

Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg

Terminated December 31, 2016.

Injection, talimogene laherparepvec, 1 million plaque forming units (pfu)

Terminated December 31, 2016.

Injection, mepolizumab, 1 mg

Terminated December 31, 2016.

Injection, irinotecan liposome, 1 mg

Terminated December 31, 2016.

Injection, necitumumab, 1 mg

Terminated December 31, 2016.

Injection, daratumumab, 10 mg

Terminated December 31, 2016.

Injection, elotuzumab, 1 mg

Terminated December 31, 2016.

Injection, sebelipase alfa, 1 mg

Terminated December 31, 2016.

Instillation, ciprofloxacin otic suspension, 6 mg

Terminated December 31, 2016.

Injection, trabectedin, 0.1 mg

Terminated December 31, 2016.

Injection, reslizumab, 1 mg

Terminated December 31, 2016.

Injection, sotalol hydrochloride, 1 mg

Injection, atezolizumab, 10 mg

Terminated December 31, 2017.

Injection, eteplirsen, 10 mg

Terminated December 31, 2017.

Injection, olaratumab, 10 mg

Terminated December 31, 2017.

Injection, granisetron extended release, 0.1 mg

Terminated December 31, 2017.

Ustekinumab, for intravenous injection, 1 mg

Terminated June 30, 2017.

Injection, conivaptan hydrochloride, 1 mg

Injection, nusinersen, 0.1 mg

Terminated December 31, 2017.

Injection, bezlotoxumab, 10 mg

Terminated December 31, 2017.

Injection, avelumab, 10 mg

Terminated December 31, 2017.

Injection, durvalumab, 10 mg

Terminated December 31, 2018.

Injection, edaravone, 1 mg

Terminated December 31, 2018.

Injection, ocrelizumab, 1 mg

Terminated December 31, 2017.

Loxapine, inhalation powder, 10 mg

Terminated December 31, 2018.

Plasma, high titer covid-19 convalescent, each unit

Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch

Percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)

Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch

Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)

Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel

Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure)

Percutaneous transluminal revascularization of acute total/subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel

Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; single vessel

Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (list separately in addition to code for primary procedure)

Endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy

Terminated December 31, 2015.

Placement of endorectal intracavitary applicator for high intensity brachytherapy

Placement and removal (if performed) of applicator into breast for intraoperative radiation therapy, add-on to primary breast procedure

Insertion of implants into the soft palate; minimum of three implants

Placement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple

Non-ophthalmic fluorescent vascular angiography

Focused ultrasound ablation/therapeutic intervention, other than uterine leiomyomata, with magnetic resonance (mr) guidance

Anoscopy; with directed submucosal injection(s), any substance

Terminated December 31, 2014.

Laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band)

Terminated June 30, 2015.

Adjunctive blue light cystoscopy with fluorescent imaging agent (list separately in addition to code for primary procedure)

Cystourethroscopy, with insertion of transprostatic implant; 1 to 3 implants

Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants

Right heart catheterization with implantation of wireless pressure sensor in the pulmonary artery, including any type of measurement, angiography, imaging supervision, interpretation, and report

Terminated December 31, 2018.

Laryngoscopy, flexible fiberoptic, with injection into vocal cord(s), therapeutic, including diagnostic laryngoscopy, if performed

Terminated December 31, 2016.

Injection/implantation of bulking or spacer material (any type) with or without image guidance (not to be used if a more specific code applies)

Terminated June 30, 2016.

Ultrasound, abdominal, with contrast

Terminated December 31, 2018.

Nasal endoscopy, surgical; balloon dilation of eustachian tube

Terminated December 31, 2020.

Transperineal implantation of permanent adjustable balloon continence device, with cystourethroscopy, when performed and/or fluoroscopy, when performed

Terminated June 30, 2019.

Ablation of prostate, transrectal, high intensity focused ultrasound (hifu), including imaging guidance

Terminated December 31, 2020.

Transurethral destruction of prostate tissue; by radiofrequency water vapor (steam) thermal therapy

Terminated December 31, 2018.

Repair of nasal vestibular lateral wall stenosis with implant(s)

Terminated December 31, 2020.

Insertion or removal and replacement of intracardiac ischemia monitoring system including imaging supervision and interpretation and peri-operative interrogation and programming; complete system (includes device and electrode)

Terminated December 31, 2018.

Bronchoscopy, rigid or flexible, transbronchial ablation of lesion(s) by microwave energy, including fluoroscopic guidance, when performed, with computed tomography acquisition(s) and 3-d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (eg, aspiration[s]/biopsy[ies]) and all mediastinal and/or hilar lymph node stations or structures and therapeutic intervention(s)

Destruction of intraosseous basivertebral nerve, first two vertebral bodies, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum

Terminated December 31, 2021.

Destruction of intraosseous basivertebral nerve, each additional vertebral body, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum (list separately in addition to code for primary procedure)

Terminated December 31, 2021.

Creation of arteriovenous fistula, percutaneous; direct, any site, including all imaging and radiologic supervision and interpretation, when performed and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization, when performed)

Terminated June 30, 2020.

Creation of arteriovenous fistula, percutaneous using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, when performed) and fistulogram(s), angiography, venography, and/or ultrasound, with radiologic supervision and interpretation, when performed

Terminated June 30, 2020.

Intraoperative near-infrared fluorescence lymphatic mapping of lymph node(s) (sentinel or tumor draining) with administration of indocyanine green (icg) (list separately in addition to code for primary procedure)

Laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and excision of herniated intervertebral disc, and repair of annular defect with implantation of bone anchored annular closure device, including annular defect measurement, alignment and sizing assessment, and image guidance; 1 interspace, lumbar

Blinded procedure for nyha class iii/iv heart failure; transcatheter implantation of interatrial shunt or placebo control, including right heart catheterization, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study

Transcatheter intraoperative blood vessel microinfusion(s) (e.g., intraluminal, vascular wall and/or perivascular) therapy, any vessel, including radiological supervision and interpretation, when performed

Non-randomized, non-blinded procedure for nyha class ii, iii, iv heart failure; transcatheter implantation of interatrial shunt, including right and left heart catheterization, transeptal puncture, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study

Cystourethroscopy, with ureteroscopy and/or pyeloscopy, with lithotripsy, and ureteral catheterization for steerable vacuum aspiration of the kidney, collecting system, ureter, bladder, and urethra if applicable (must use a steerable ureteral catheter)

Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with strain imaging

Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with stress imaging

Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, includes angioplasty within the same vessel(s), when performed

Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessel(s), when performed

Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel(s), when performed

Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel(s), when performed

Endoscopic ultrasound-guided direct measurement of hepatic portosystemic pressure gradient by any method (list separately in addition to code for primary procedure)

Cystourethroscopy, with insertion of temporary prostatic implant/stent with fixation/anchor and incisional struts

Vitrectomy, mechanical, pars plana approach, with subretinal injection of pharmacologic/biologic agent

Nasal/sinus endoscopy, cryoablation nasal tissue(s) and/or nerve(s), unilateral or bilateral

Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies), with intravascular lithotripsy, includes angioplasty within the same vessel (s), when performed

Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessel(s), when performed

Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel (s), when performed

Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel (s), when performed

Intraoperative near-infrared fluorescence imaging of major extra-hepatic bile duct(s) (e.g., cystic duct, common bile duct and common hepatic duct) with intravenous administration of indocyanine green (icg) (list separately in addition to code for primary procedure)

Esophageal mucosal integrity testing by electrical impedance, transoral, includes esophagoscopy or esophagogastroduodenoscopy

Colpopexy, vaginal; minimally invasive extra-peritoneal approach (sacrospinous)

Endoscopic submucosal dissection (esd), including endoscopy or colonoscopy, mucosal closure, when performed

Insertion of central venous catheter through central venous occlusion via inferior and superior approaches (e.g., inside-out technique), including imaging guidance

Arthroscopy, shoulder, surgical; with implantation of subacromial spacer (e.g., balloon), includes debridement (e.g., limited or extensive), subacromial decompression, acromioplasty, and biceps tenodesis when performed

Blinded procedure for new york heart association (nyha) class ii or iii heart failure, or canadian cardiovascular society (ccs) class iii or iv chronic refractory angina; transcatheter intramyocardial transplantation of autologous bone marrow cells (e.g., mononuclear) or placebo control, autologous bone marrow harvesting and preparation for transplantation, left heart catheterization including ventriculography, all laboratory services, and all imaging with or without guidance (e.g., transthoracic echocardiography, ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study

Blinded procedure for transcatheter implantation of coronary sinus reduction device or placebo control, including vascular access and closure, right heart catherization, venous and coronary sinus angiography, imaging guidance and supervision and interpretation when performed in an approved investigational device exemption (ide) study

Gastric restrictive procedure, endoscopic sleeve gastroplasty, with esophagogastroduodenoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components

Endoscopic outlet reduction, gastric pouch application, with endoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components

Echocardiography image post processing for computer aided detection of heart failure with preserved ejection fraction, including interpretation and report

Gastric electrophysiology mapping with simultaneous patient symptom profiling

Dermal injection procedure(s) for facial lipodystrophy syndrome (lds) and provision of radiesse or sculptra dermal filler, including all items and supplies

Terminated December 31, 2016.

Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source

Radiolabeled product provided during a hospital inpatient stay

Implanted prosthetic device, payable only for inpatients who do not have inpatient coverage